JPMorgan Chase & Co. Issues Pessimistic Forecast for Surgery Partners (NASDAQ:SGRY) Stock Price

Surgery Partners (NASDAQ:SGRY) had its target price reduced by equities researchers at JPMorgan Chase & Co. from $27.00 to $20.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 19.44% from the company’s previous close.

Several other analysts also recently issued reports on SGRY. UBS Group decreased their target price on Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, November 13th. Bank of America started coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a “buy” rating and a $28.00 price objective for the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, November 17th. Mizuho dropped their target price on shares of Surgery Partners from $28.00 to $22.00 and set an “outperform” rating for the company in a research report on Monday, November 17th. Finally, Royal Bank Of Canada reduced their price target on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a report on Tuesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Surgery Partners presently has an average rating of “Moderate Buy” and a consensus price target of $27.44.

Surgery Partners Price Performance

Surgery Partners stock traded up $0.91 during mid-day trading on Monday, hitting $16.75. The stock had a trading volume of 449,355 shares, compared to its average volume of 1,479,197. The firm has a market capitalization of $2.17 billion, a P/E ratio of -11.70 and a beta of 1.85. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. The firm’s 50 day moving average is $20.29 and its 200 day moving average is $21.69. Surgery Partners has a one year low of $14.94 and a one year high of $26.16.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business had revenue of $821.50 million for the quarter, compared to the consensus estimate of $823.55 million. During the same period in the prior year, the business earned $0.19 earnings per share. Surgery Partners’s revenue was up 6.6% compared to the same quarter last year. Surgery Partners has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Surgery Partners will post 0.67 earnings per share for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In other news, insider Harrison R. Bane sold 9,339 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the transaction, the insider owned 117,181 shares of the company’s stock, valued at approximately $2,634,228.88. The trade was a 7.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.70% of the company’s stock.

Institutional Trading of Surgery Partners

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. AlphaQuest LLC boosted its position in shares of Surgery Partners by 112.0% during the first quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after buying an additional 559 shares during the period. Jones Financial Companies Lllp boosted its holdings in Surgery Partners by 313.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after acquiring an additional 930 shares during the period. PNC Financial Services Group Inc. grew its position in Surgery Partners by 86.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after acquiring an additional 542 shares during the last quarter. Summit Securities Group LLC bought a new position in Surgery Partners in the 1st quarter valued at $31,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in Surgery Partners by 45,640.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock worth $49,000 after purchasing an additional 2,282 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.